Alzamend Neuro director Milton C. Ault III acquires 108,388 shares for $108,897
PUBT · 04/16 20:31
Share
Listen to the news
- Alzamend Neuro director Milton C. Ault III reported an indirect purchase of 108,388 common shares at USD 1.
- Indirect stake held via Ault Lending rose to 116,648 common shares following transaction.
- Indirect holdings also included 11,068 common shares via Ault Life Sciences.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-004742), on April 16, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending